Synthesis and biological evaluation of sophocarpinic acid derivatives as anti-HCV agents

Acta Pharmaceutica Sinica B - Tập 4 - Trang 307-312 - 2014
Yinghong Li1, Zonggen Peng1, Limei Gao1, Danqing Song1
1Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China

Tài liệu tham khảo

Mohd Hanafiah, 2013, Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence, Hepatology, 57, 1333, 10.1002/hep.26141 Fan, 2013, Attributable causes of liver cancer mortality and incidence in china, Asian Pac J Cancer Prev, 14, 7251, 10.7314/APJCP.2013.14.12.7251 Xiang, 2011, Viral sequence evolution in Chinese genotype 1b chronic hepatitis C patients experiencing unsuccessful interferon treatment, Infect Genet Evol, 11, 382, 10.1016/j.meegid.2010.11.011 Melnikova, 2008, Hepatitis C therapies, Nat Rev Drug Discov, 7, 799, 10.1038/nrd2661 Zeuzem, 2008, Interferon-based therapy for chronic hepatitis C: current and future perspectives, Nat Clin Pract Gastroenterol Hepatol, 5, 610, 10.1038/ncpgasthep1274 Susser, 2009, Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients, Hepatology, 50, 1709, 10.1002/hep.23192 Sarrazin, 2007, Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir, Gastroenterol, 132, 1767, 10.1053/j.gastro.2007.02.037 Lok, 2012, Preliminary study of two antiviral agents for hepatitis C genotype 1, N Engl J Med, 366, 216, 10.1056/NEJMoa1104430 McCown, 2009, GT-1a or GT-1b subtype-specific resistance profiles for hepatitis C virus inhibitors telaprevir and HCV-796, Antimicrob Agents Chemother, 53, 2129, 10.1128/AAC.01598-08 Delemos, 2014, Hepatitis C treatment: an incipient therapeutic revolution, Trends Mol Med, 20, 315, 10.1016/j.molmed.2014.02.002 Lam, 2012, Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus, Antimicrob Agents Chemother, 56, 3359, 10.1128/AAC.00054-12 Li, 2005, Anti-HBV effect of liposome-encapsulated matrine in vitro and in vivo, World J Gastroenterol, 11, 426, 10.3748/wjg.v11.i3.426 Long, 2004, Efficacy of intramuscular matrine in the treatment of chronic hepatitis B, Hepatobiliary Pancreat Dis Int, 3, 69 Zhang, 2007, Progress of research and application of matrine-type alkaloids, Prog Mod Biomed, 7, 451 Du, 2013, N-Substituted benzyl matrinic acid derivatives inhibit hepatitis C virus (HCV) replication through down-regulating host heat-stress cognate 70 (Hsc70) expression, PLoS One, 8, e58675, 10.1371/journal.pone.0058675 Li, 2014, Synthesis and biological evaluation of matrinic acid derivatives as anti-hepatitis C virus agents, Chin Sci Pap, 9, 321 Gao, 2011, Design and synthesis of oxymatrine analogs overcoming drug resistance in hepatitis B virus through targeting host heat stress cognate 70, J Med Chem, 54, 869, 10.1021/jm101325h Li, 2011, Synthesis, structure-activity relationship and biological evaluation of anticancer activity for novel N-substituted sophoridinic acid derivatives, Bioorg Med Chem Lett, 21, 5251, 10.1016/j.bmcl.2011.07.038 Gao, 2013, Synthesis and biological evaluation of N-substituted sophocarpinic acid derivatives as coxsackievirus B3 inhibitors, Chem Med Chem, 8, 1545, 10.1002/cmdc.201300224 Peng, 2010, Small molecular compounds that inhibit hepatitis C virus replication through destabilizing heat shock cognate 70 messenger RNA, Hepatology, 52, 845, 10.1002/hep.23766